Brief: AC Immune Q2 Operating Income CHF -19.388 Million
05/08/2025 12:00
Aug 05 (Reuters) - AC Immune Q2 operating expenses CHF -20.694 million. Q2 pretax profit CHF -21.189 million Q2 net income CHF -21.189 million Q2 EPS CHF -0.21
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture